56 results
DEFA14A
ALGS
Aligos Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:04pm
Materials
Soliciting Material under §240.14a-12
ALIGOS THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
P.O. BOX 8016, CARY, NC 27512
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Materials
Soliciting Material under §240.14a-12
ALIGOS THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
ALIGOS THERAPEUTICS, INC
SC TO-I
EX-99
1v5w9a7y no6sx1
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
tcp9jq 1pevvtxeze
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
bbag7040ptc ymdzr
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
bwlx6 hq0
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
fkly6alhezju
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
sf73dcky9j02ayl4
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
95ti0iqeso 39alw
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
vwimz2a
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-C
o5ksvx
25 Jan 24
Information about tender offer
6:12am
8-K
EX-99.1
ae3rifup x5p
25 Jan 24
Other Events
6:06am
8-K
h5kh1ndqbweqywdlyd
25 Jan 24
Other Events
6:06am
D
j8ko rl1eyza
7 Nov 23
$92.15 mm in equity / options / securities to be acquired, sold $92.15 mm, 11 investors
12:03pm
8-K
EX-10.1
51a wgkdjt368672snvm
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm